Judah Weinstein
Internal Medicine · New York, NYNPI 1588939821
Payments from drug & device makers
Across 36 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$190
- Lilly USA, LLC$185
- Daiichi Sankyo Inc.$69
- Sanofi$54
- Takeda Pharmaceuticals U.S.A., Inc.$50
- Phathom Pharmaceuticals, Inc.$48
- plus $171 from 6 others
What the payments were for
- Food & beverage$767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $190 |
| Lilly USA, LLC | 9 | $185 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Sanofi | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $48 |
| Gilead | 2 | $48 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
| Vivus LLC | 2 | $31 |
| Ardelyx, Inc. | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $18 |
How this compares
$767 in reported general payments places this provider in the 65th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $10,047 |
| Amoxicillin-Clavulanate Pot ErAmoxicillin/Potassium Clav | 12 | $7,326 |
| Atorvastatin Calcium | 63 | $501 |
| Levothyroxine Sodium | 14 | $250 |
| Rosuvastatin Calcium | 17 | $162 |
| Amlodipine Besylate | 29 | $144 |
| Losartan Potassium | 18 | $118 |
| Fluticasone Propionate | 16 | $115 |
| Metformin Hcl | 19 | $85 |
| Escitalopram Oxalate | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New York
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- Sally LauNew York$8.4M
- Maria RubinsteinNew York$6.3M
- Dana RathkopfNew York$6M
- Eytan SteinNew York$5.8M
- James GreenwaldNew York$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.